Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival … MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ... Breast cancer 21, 677-683, 2014 | 46 | 2014 |
Diagnostic potential of serum direct markers and non‐invasive fibrosis models in patients with chronic hepatitis B Ö Gümüşay, S Özenirler, A Atak, C Sönmez, S Özkan, AF Tuncel, ... Hepatology Research 43 (3), 228-237, 2013 | 44 | 2013 |
Pembrolizumab for early triple-negative breast cancer B Cetin, O Gumusay, P Schmid, R Dent, J O’Shaughnessy N Engl J Med 382 (26), e108, 2020 | 43 | 2020 |
Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C GA Seren Ozenirler, Gulbanu Erkan, Ozlem Gulbahar, Ozge (Gumusay) Bostankolu ... Turk J Gastroenterol 22 (1), 47-53, 2011 | 38 | 2011 |
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer LA Huppert, O Gumusay, D Idossa, HS Rugo CA: A Cancer Journal for Clinicians 73 (5), 480-515, 2023 | 35 | 2023 |
Immunotherapy toxicity: Identification and management O Gumusay, J Callan, HS Rugo Breast Cancer Research and Treatment 192 (1), 1-17, 2022 | 32 | 2022 |
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites O Gumusay, M Benekli, O Ekinci, M Baykara, A Ozet, U Coskun, ... Japanese journal of clinical oncology 45 (5), 416-421, 2015 | 31 | 2015 |
Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology) MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ... Oncology 83 (3), 141-150, 2012 | 27 | 2012 |
Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology M KÜÇÜKÖNER, A Isikdogan, S Yaman, O Gumusay, O Unal, A Ulas, ... Asian Pacific Journal of Cancer Prevention 13 (8), 2012 | 27 | 2012 |
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme B Cetin, II Gonul, O Gumusay, I Bilgetekin, E Algin, A Ozet, A Uner Neuropathology 38 (5), 457-462, 2018 | 26 | 2018 |
Advances of molecular targeted therapy in gastric cancer B Cetin, O Gumusay, M Cengiz, A Ozet Journal of gastrointestinal cancer 47, 125-134, 2016 | 24 | 2016 |
Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma B Cetin, B Afsar, SM Deger, II Gonul, O Gumusay, A Ozet, M Benekli, ... International urology and nephrology 46, 1081-1087, 2014 | 22 | 2014 |
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology O Gumusay, U Coskun, T Akman, AS Ekinci, M Kocar, ÖB Erceleb, ... Journal of cancer research and clinical oncology 140, 151-157, 2014 | 18 | 2014 |
Factors influencing chemotherapy goal perception in newly diagnosed cancer patients O Gumusay, B Cetin, M Benekli, G Gurcan, MN Ilhan, B Bostankolu, ... Journal of Cancer Education 31, 308-313, 2016 | 16 | 2016 |
Emerging treatment strategies for metastatic triple-negative breast cancer LA Huppert, O Gumusay, HS Rugo Therapeutic advances in medical oncology 14, 17588359221086916, 2022 | 15 | 2022 |
Yaşlı Hastalarda Kanser Kemoterapisi. Ö Bostankolu, B Öztürk, U Coşkun, S Büyükberber, M Benekli UHOD: International Journal of Hematology & Oncology/Uluslararasi Hematoloji …, 2008 | 15 | 2008 |
Small cell neuroendocrine carcinoma of the posterior tongue O Gumusay, G Yilmaz, U Aydil, A Ozet, G Tufan, O Erdem, Y Kizil, ... Journal of Cancer Research and Therapeutics 11 (3), 651, 2015 | 12 | 2015 |
CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer B Cetin, CA Wabl, O Gumusay Future Oncology 18 (9), 1143-1157, 2022 | 11 | 2022 |
Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology O Ercelep, TO Topcu, IV Bayoglu, AS Ekinci, S Koca, H Kavgaci, ... Tumor Biology 37 (9), 12033-12038, 2016 | 11 | 2016 |
The DNA damaging revolution B Cetin, CA Wabl, O Gumusay Critical Reviews in Oncology/Hematology 156, 103117, 2020 | 10 | 2020 |